SANJ K. PATEL

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

BIOCRYST PHARMACEUTICALS INC

Filing Date Source Excerpt
2016-04-11 Sanj K. Patel was appointed to the Board in September 2015. ... Mr. Patel's scientific, clinical and commercial experience in the pharmaceutical industry as well as his experience as CEO for a public company provide valuable expertise for the Company's Board.
2017-04-12 Sanj K. Patel was appointed to the Board in September 2015. ... He is the Chairman and CEO of Kiniksa Pharmaceuticals. ... 2016 Director Compensation table shows Sanj K. Patel total compensation of $120,477.
2018-09-28 The following table provides information related to the compensation of our non-employee directors during fiscal 2017.
Name Fees Earned ($) Option Award ($) (1) (2) Non-Equity Incentive Plan Compensation All Other Compensation Total ($)
Sanj K. Patel 62,500 104,664 - - 167,164

Data sourced from SEC filings. Last updated: 2026-02-03